Moreover, SOX1 has been observed among the set of genes with elevated expression in CD44+/CD24− and CD133+ breast cancer stem cells50 and in invasive prostate cancer cells, where SOX1 promoter was hypomethylated51. This evidence concerns the gene CD24 and breast cancer.